| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/07/2005 | US20050148578 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148572 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 07/07/2005 | CA2550888A1 Vinylogous 4h-pyrones and their use in promoting plant growth |
| 07/07/2005 | CA2550643A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548494A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1549641A1 Antimicrobial 3.1.0 bicyclic oxazolidinone derivatives |
| 07/06/2005 | EP1549156A1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 07/06/2005 | EP1280809B1 Antitumoral ecteinascidin derivatives |
| 07/06/2005 | CN1634921A Crystalline anti-cholinergic tiotropium crystal |
| 07/06/2005 | CN1634894A Spiro[benzocyclo-4'-piperidine-2'-one] template compound and method for preparing same |
| 07/06/2005 | CN1209107C Carbazolyl alkaloid anticarcinogen and its prepn |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 07/05/2005 | CA2183972C Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 06/30/2005 | WO2005058912A1 Process for preparing amide acetals |
| 06/30/2005 | WO2005058910A1 The method of manufacturing of 7-ethyl-10-hydroxycamptothecin |
| 06/30/2005 | WO2005058893A1 Tricyclic benzimidazoles |
| 06/30/2005 | WO2005058843A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/30/2005 | WO2005058325A1 Tricyclic imidazopyridines for use as gastric secretion inhibitors |
| 06/30/2005 | WO2005058231A2 Rifamycin analogs and uses thereof |
| 06/30/2005 | WO2005033113A3 Indole derivatives |
| 06/30/2005 | WO2004089926A3 Genipin derivatives and uses thereof |
| 06/30/2005 | US20050143443 4-substituted pyrrole-2-carboxylic acidsand 5-substituted pyrazole-3-carboxylic acids/esters/salts; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143421 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050143382 Heterocyclic compounds as pharmaceutically active compounds |
| 06/30/2005 | US20050143373 Benzodioxole derivatives |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050142601 Nucleic acids encoding an enediyne polyketide synthase complex |
| 06/30/2005 | US20050142322 Optical recording media and dipyrrpomethene-metal chelate compounds |
| 06/30/2005 | US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders |
| 06/30/2005 | DE10354629A1 2-Ethyl-4,6-dimethyl-phenyl substituierte spirocyclische Tetramsäure-Derivate 2-ethyl-4,6-dimethyl-phenyl substituted spirocyclic tetramic acid derivatives |
| 06/30/2005 | CA2549042A1 Tricyclic benzimidazoles |
| 06/30/2005 | CA2549030A1 Tricyclic imidazopyridines for use as gastric secretion inhibitors |
| 06/30/2005 | CA2549001A1 Rifamycin analogs and uses thereof |
| 06/30/2005 | CA2548273A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/30/2005 | CA2547519A1 Process for preparing amide acetals |
| 06/29/2005 | EP1546391A2 Energy transfer dyes, terminators and use thereof |
| 06/29/2005 | EP1546151A1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| 06/29/2005 | EP1546143A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 06/29/2005 | EP1546137A1 Benzimidazol-1-yl-thiophene compounds for the treatment of cancer |
| 06/29/2005 | EP1546125A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 06/29/2005 | EP1545545A2 COMPOUNDS WITH THE BICYCLO 4.2.1 NONANE SYSTEM FOR THE TREATMENT OF i FLAVIVIRIDAE /i INFECTIONS |
| 06/29/2005 | EP1545502A2 Keto cannabinoids with therapeutic indications |
| 06/29/2005 | EP1545211A1 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 06/29/2005 | CN1633434A Imidazo[1, 2-a]pyridine derivative |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1631879A Substituted phenyl keto enols as pesticides and herbicides |
| 06/29/2005 | CN1631878A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 06/28/2005 | US6912470 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents |
| 06/28/2005 | US6911543 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 06/28/2005 | US6911445 For reatment of depression, childhood depression, dysthymia, anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, attention deficit disorder, obsessive-compulsive disorder, cocaine and alcohol addiction |
| 06/23/2005 | WO2005057207A1 Trityl derivatives for enhancing mass spectrometry |
| 06/23/2005 | WO2005056554A2 Azepinoindole derivatives as pharmaceutical agents |
| 06/23/2005 | WO2005056524A2 Therapeutic agents useful for treating pain |
| 06/23/2005 | WO2005033930A3 Process for upgrading naphtha |
| 06/23/2005 | WO2005030333A3 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 06/23/2005 | WO2004089307A8 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 06/23/2005 | US20050137221 Keratinocyte-proliferative diseases; inhibitor of solubilization of Epidermal Growth Factor; 3,4,5-trihydroxy-1-(4'-methoxybenzenesulfonyl)-piperidine-2-carboxylic acid hydroxamide; 7-acetoxy-5-(4'-methoxybenzenesulfonyl)-2,2-dimethyl-h exahydro-[1,3]dioxolo[4,5-c]pyridine-6-carboxy ester intermediate |
| 06/23/2005 | US20050137219 alzheimer's disease; schizophrenia |
| 06/23/2005 | US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors |
| 06/23/2005 | US20050137201 Compositions useful as inhibitors of protein kinases |
| 06/23/2005 | US20050137191 Nitrate esters and their use for mitigating cellular damage |
| 06/23/2005 | US20050137189 For therapy of Gram-positive bacterial infection |
| 06/23/2005 | US20050137187 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 06/22/2005 | EP1543011A2 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 06/22/2005 | EP1542674A1 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 06/22/2005 | EP1525265A4 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 06/22/2005 | EP1007533B1 Bioconjugates and delivery of bioactive agents |
| 06/22/2005 | CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 06/22/2005 | CN1630639A Novel pyridine- and quinoline-derivatives |
| 06/22/2005 | CN1629145A Condensed heteroaryl derivatives |
| 06/21/2005 | WO2005066180A1 Cysteine protease inhibitors |
| 06/21/2005 | US6909001 Cyclization of salicaldehyde with 3-(2-furyl)-3-oxopropane-nitrile, to form 2-amino-4-(2-furyl)-5H-chromeno(2,3-b) pyridine-3-carbonitrile, used as mitogen activated protein kinase inhibitors |
| 06/21/2005 | US6908927 Reduction physical cigarette smoking |
| 06/21/2005 | US6908922 Linear cyclic ureas |
| 06/21/2005 | CA2108068C Carbamates of rapamycin |
| 06/16/2005 | WO2005054251A1 New cartharidic amine, demethyl cartharidic amine derivatives and their medicinal use |
| 06/16/2005 | WO2005054249A1 Novel compounds |
| 06/16/2005 | WO2005054234A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy |
| 06/16/2005 | WO2005054205A1 Protein modifier production inhibitor |
| 06/16/2005 | WO2005054203A1 Quinoline derivatives substituted by aliphatic amino groups, the preparation and the pharmaceutical use thereof |
| 06/16/2005 | WO2005054183A2 Quinolinone based protein kinase inhibitors |
| 06/16/2005 | WO2005053692A1 Advanced quinolinone based protein kinase inhibitors |
| 06/16/2005 | WO2005053688A1 Substituted furo[2,3-g] indazoles for the treatment of glaucoma |
| 06/16/2005 | WO2005016255A3 Substituted tetrahydroquinolines, phenylacetic acids and benzoic acids as hepatocyte nuclear factor 4 (hnf-4 ) modulator compounds |
| 06/16/2005 | WO2005005430A3 Process for the preparation of furopyrroles |
| 06/16/2005 | WO1990000853A8 Method of treating neurological disorders |
| 06/16/2005 | US20050131177 1-Alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 06/16/2005 | US20050131164 Dehydration mixture of oxyamides; reacting acid or ester with dialkanolamine |
| 06/16/2005 | US20050131051 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon |
| 06/16/2005 | US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 06/16/2005 | US20050131007 Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof |
| 06/16/2005 | US20050131003 Heterocyclic compounds |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |